The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
In this valuable study, the authors develop new approaches to investigate mRNA imprinting, a phenomenon in which RNA-protein complexes form in the nucleus to influence the fate of transcripts in the ...
Recent advances in biomedical technologies—including microphysiological systems (MPS), humanized and chimeric animal models, nanomaterials, cell-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results